This study was supported by the National High Technology Research and Development Program of China (No. 2012AA02A508 ); National Natural Science Foundation of China (No. 81301112 ); and the International Science and Technology Cooperative Program (No. 2012DFA30470 ).
第一作者机构：[1]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;[2]Beijing Inst Brain Disorders, Beijing, Peoples R China;[3]Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China;[4]Chinese Glioma Genome Atlas Network, Beijing, Peoples R China;
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;[2]Beijing Inst Brain Disorders, Beijing, Peoples R China;[3]Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China;[4]Chinese Glioma Genome Atlas Network, Beijing, Peoples R China;[5]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China;[7]Beijing Neurosurg Inst, 6 Tiantan Xili, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Zheng,Zhang Zhong,Wang Yinyan,et al.Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?"[J].EPILEPSY RESEARCH.2015,115:145-146.doi:10.1016/j.eplepsyres.2015.06.004.
APA：
Wang, Zheng,Zhang, Zhong,Wang, Yinyan,You, Gan&Jiang, Tao.(2015).Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?".EPILEPSY RESEARCH,115,
MLA：
Wang, Zheng,et al."Response to "Association of IDH1/2 mutation with preoperative seizure in low-grade gliomas: How strong is the evidence?"".EPILEPSY RESEARCH 115.(2015):145-146
